Maui Derm NP+PA Fall 2024 Program

September 15-18, 2024 • Gaylord Opryland  •  Nashville, TN

TimeSunday, September 15, 2024Faculty
7:00 am – 7:50 am Breakfast, Exhibits & Registration
7:50 am – 8:00 am Welcome & Program Overview
8:00 am – 9:30 am Literature from 2023 & 2024 in Review
Drs. Ted Rosen, Sheila Fallon Friedlander and Matt Zirwas will discuss the most noteworthy articles from a wide array of journals published in the last year.
T. Rosen, MD
S. Fallon-Friedlander, MD
M. Zirwas, MD
9:30 am – 10:30 amNew Products and New Therapies
Drs. Ted Rosen and George Martin will discuss the newest drugs and therapies and how you will be using them in 2024 and beyond.   
T. Rosen, MD
G. Martin, MD
10:30 am -11:15 amBreaks + Exhibits
11:15 am – 12:45 pmUpdate Cutaneous Oncology 2024 – New Interactive Format
Drs. Rosen and Martin will cover their approach from AKs to advanced BCC and SCC. In the second part of the session, a series of challenging case scenarios will be presented. Attendees will then be asked during case studies to weigh in on their selection of therapies on a survey app. Drs. Rosen and Martin will then discuss the rationale for their therapeutic selection.
T. Rosen, MD
G. Martin, MD
12:45 pm – 1:15 pmTalk Story
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater.
T. Rosen, MD
G. Martin, MD
M. Zirwas, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm
Product Theater Lunch (Non-CME) Optional non-certified lunches designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm
Dessert Product Theater (Non-CME)
Optional NON-CME product theater designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
2:15 pm – 4:00 pmPsoriasis and Psoriatic Arthritis Update 2024 – New Interactive Format
Our expert faculty will discuss what is new in PsO and PsA in the last year, including new drugs and therapies. In the second part of the session, a series of challenging case scenarios in PsO and PsA will be presented. Attendees will then be asked during case studies to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection.
J. Hawkes, MD
M. Young, MSN, ANP-c
6:00 pm – 7:00 pmWelcome Reception
TimeMonday, September 16, 2024Faculty
7:00 am – 7:55 amBreakfast + Exhibits
7:55 am – 8:00 amMorning Announcements
8:00 am – 9:00 am Infectious Disease Update
Drs. Rosen and Friedlander will discuss diagnostic and therapeutic challenges in children and adults covering a range of viral, bacterial, fungal, parasitic and arthropod diseases. 
T. Rosen, MD
S. Fallon Friedlander, MD
9:00 am – 9:45 amConnective Tissue Disorders Update 2024
Lupus, Scleroderma, Dermatomyositis and more. What are the latest in diagnostic and therapeutic developments in connective tissue disorders. Learn from one of the world experts in connective tissue disorders.
TBD
9:45 am – 10:30 amDisorders of Pigmentation
Disorders of pigmentation are part of everyday dermatology practice. In this session our faculty will discuss their approach to disease states such as melasma, vitiligo and more. During the case based discussion, they will share their diagnostic approach, including differential diagnoses to consider, and the latest strategies used to manage a wide range of pigmentation disorders.
V. Callender, MD
10:30am -11:15amBreaks + Exhibits
11:15 am – 12:15 pmGrand Rounds in Dermatology – New Interactive Format
Our expert faculty will present cases that challenged their clinical skills in making the diagnosis and deciding on a therapeutic regimen. After being presented with the clinical scenario, attendees will be asked to weigh in on their selection of therapies on the meeting app. Our faculty will then discuss the rationale for their therapeutic selection. Pay attention as each case that will be presented required an extensive differential diagnosis and, in some cases, a diagnostic workup and full armamentarium of therapeutic agents.
Moderator:
G. Martin MD

Faculty:
T. Rosen MD
and others
12:15 pm – 12:45 pmThe Challenge of the Lower Leg Ulcer
Lower leg ulcers present to our clinic on a regular basis. Figuring out what caused them can be a complicated issue. Your immediate and long-term diagnostic and therapeutic strategies need a working diagnosis. Traumatic, vascular, systemic disease associated, infectious are among the causes of leg ulcers that require you to establish a diagnostic and therapeutic plan. Dr. Grada, dermatologist and leading expert in this arena, will walk you through a number of clinically challenging cases and his diagnostic and therapeutic approach to them.
A. Grada, MD
12:45 pm – 1:15 pmTalk Story
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater.
A. Grada, MD
T. Rosen, MD
G. Martin, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm
Product Theater Lunch (Non-CME)
Optional non-certified lunches designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
INDUSTRY HOSTED EVENT
1:45 pm – 2:15 pm
Dessert Product Theater (Non-CME)
Optional NON-CME product theater designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
2:15 pm – 3:00 pmHidrandenitis Suppuritiva Update 2024
HS is one of the most challenging clinical situations managed by the dermatologist. A combination of medical and surgical management strategies is needed to optimize therapies. The introduction of new therapies and how they will be used will be discussed.
R. Chovatiya MD, PhD
3:00 pm – 4:00 pmAcute & Chronic Spontaneous Uriticaria: Diagnostic and Therapeutic Strategies
Dr. Hawkes will present a series of challenging cases in urticaria that will test your knowledge in making the correct diagnosis and appropriate therapy. Attendees , after being presented with a wide range of clinical scenarios will be asked to weigh in on their selection of therapies on a survey app. Dr. Hawkes will then discuss the rationale for his therapeutic selection.
J. Hawkes, MD
TimeTuesday, September 17, 2024Faculty
7:00 am – 7:55 am Breakfast + Exhibits
7:55 am – 8:00 am Morning Announcements
8:00 am – 9:00 am Pediatric Dermatology Update 2024
Three of the foremost pediatric dermatologists will bring the latest in diagnostic and therapeutic approaches to a wide range of diagnostic and therapeutic scenarios involving neonates and children.
V. Oza, MD
G. Hightower, MD, PhD
A. Y. Kirkorian, MD
9:00 am – 10:30 amAtopic Dermatitis and Itch Update 2024 – New Interactive Format
New drugs, new data, new approaches to treating atopic dermatitis and itch will be discussed in the first part of the session. In the last part of the session, a series of challenging case scenarios will be presented. After being presented with the clinical scenario, attendees will be asked to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection.
M. Zirwas, MD
10:30 am -11:15 amBreaks + Exhibits
11:00 am – 12:45 pmAcne and Rosacea Update 2024 – New Interactive Format
Drs. Hilary Baldwin, Julie Harper and James Del Rosso will discuss the latest in their approach to treating acne and rosacea. In the second part of the session, a series of challenging case scenarios will be presented. After being presented with case scenarios, attendees will then be asked to weigh in on their selection of therapies on a survey app. Our faculty will then discuss the rationale for their therapeutic selection.
H. Baldwin, MD
J. Harper, MD
J. Del Rosso, DO
12:45 pm – 1:15 pmTalk Story
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater.
G. Martin, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm
Product Theater Lunch (Non-CME)
Optional non-certified lunches designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
1:45 pm – 2:15 pmDessert Product Theater (Non-CME)
Optional NON-CME product theater designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
2:15 pm – 3:15 pmLightening Round: Skin Lesions Associated with Systemic Disease
During this interactive session our faculty will present a series of challenging clinical photos and you will be asked to select the correct answer. The skin lesions are clues to underlying systemic disease. Test your clinical acumen against your peers!
Moderator:
G. Martin, MD

Faculty:
T. Rosen, MD
J. Hawkes, MD
S. Fallon Friedlander, MD
and others
3:15 pm – 4:15 pmContact Dermatitis: Cases that will leave you scratching your head – New Interactive Format
Dr. Zirwas will present a series of cases that will have you “scratching your head” in coming up with a diagnosis. Learn as our contact dermatitis “super sleuths” lead you on a diagnostic and therapeutic journey during a wide range of “eczematous conditions”. Attendees, after being presented with case scenarios, will then be asked to weigh in on their diagnosis and therapeutic choices on a survey. Our faculty will then discuss the rationale for their diagnostic and therapeutic selection.
M. Zirwas, MD
TimeWednesday, September 18, 2024Faculty
7:00 am – 7:55 am Breakfast + Exhibits
7:55 am – 8:00 am Morning Announcements
8:00 am – 8:50 am Blistering Diseases: What’s the Diagnosis – New Interactive Format
Dr. Donna Culton will present a series of blistering disease cases that will challenge your diagnostic and therapeutic acumen. Attendees, after being presented with case scenarios, will then be asked to weigh in on their diagnosis and therapeutic choices on the survey app. Dr. Culton will then discuss the diagnosis and the rationale for her therapeutic selection.
D. Culton, MD, PhD
9:50 am – 10:00 amHair Update 2024
As the song goes, “nobody does it better”. Dr. Jerry Shapiro continues to deliver the most comprehensive and cutting edge talk on non-scarring and scarring alopecias.
J. Shapiro, MD
10:00 am -10:45 amBreaks + Exhibits
10:45 am – 12:45 pmPigmented Lesion Clinic – New Interactive Format
Take three world experts in the diagnosis and management of pigmented lesions – a pediatric dermatologist, a dermatologist and a dermatopathologist – and have them discuss their approach to a wide array of clinical scenarios involving the spectrum of pigmented lesions from congenital nevi to metastatic melanoma. They will present a series of pigmented lesion cases that will challenge your diagnostic and therapeutic acumen. After being presented with case scenarios, attendees will be asked to weigh in on their diagnosis and therapeutic choices on the survey app. The faculty will then discuss the diagnosis and the rationale for her therapeutic selection.
H. Tsao, MD, PhD
E. Hawryluk, MD, PhD
A. Marghoob, MD
12:45 pm – 1:15 pmTalk Story
During this 30-minute NON-CME session our faculty will do “Q&A” from their session during the first 15 minutes. The final 15 minutes of the Talk Story will allow attendees to get lunch and prepare for the Product Theater.
H. Tsao, MD, PhD
A. Marghoob, MD
INDUSTRY HOSTED EVENT
1:15 pm – 1:45 pm
Product Theater Luncheon (Non-CME)
Optional non-certified lunches designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
1:45 pm – 2:15 pmDessert Product Theater (Non-CME)
Optional NON-CME product theater designed to cover therapeutic approaches to a particular disease state. Industry sponsored.
2:15 pm – 4:45 pmWorkshop: Dermoscopy on Special Sites
Simply described as “the best dermoscopy workshop you will ever attend”. Dr. Ash Marghoob will hold his internationally acclaimed workshop on dermoscopy. This year’s workshop is designed to bring attendees up to date with current interpretation of dermoscopic features of specific sites such as the hands and feet, lips, etc. His algorithm and pattern analysis to assist in detecting skin cancer will be stressed. This knowledge will be applied to a set of unknowns, which the audience will help analyze.
A. Marghoob, MD